Vaccination not only prevents disease caused by acute infection but also protects against long-term immune-related sequelae that can follow an acute viral infection. This is the main conclusion of a study led by the Infection Biology Laboratory at Pompeu Fabra University. The study, carried out in mice, shows how after recovering from an acute viral infection, animals experienced a long period of impaired immune responsiveness which compromised their immune system's ability to effectively respond to future challenges. Prior vaccination prevented these detrimental consequences, preserving immune function, thus broadening our understanding of the benefits of vaccination.  

SAN ANTONIO — October 6, 2026 — Southwest Research Institute (SwRI) and The University of Texas at San Antonio (UT San Antonio) will work together to identify new peptide catalysts for medicinal applications. The project is part of the Connecting through Research Partnerships (Connect) program, that started in 2010 to foster more collaborative research between SwRI and UT San Antonio.

Chiba University’s Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa) and the Noguchi Memorial Institute for Medical Research (NMIMR) at the University of Ghana signed an MOU to build a global research hub and establish a sustainable joint research framework.

Manufacturing modern medicines is a multi-stage process, and each step introduces the opportunity for contamination, which can be both deadly and expensive. Penn State chemical engineering doctoral candidate Shreya Kapila is working to improve the sterilization process by surface-modifying the membranes used to sterile filter pharmaceutical products and remove bioburden. She conducts research in the laboratory of Andrew Zydney, Bayard D. Kunkle Chair and professor of chemical engineering at Penn State.